Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals shares soared 28.99 percent on volume of over 4 million shares traded Friday to close at $4.36 a share. The company announced their net loss shrunk to $0.3 million for the fourth quarter of 2012, compared to a net loss of $10.7 million a year prior.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on